Statine in der Primärprävention, ja oder nein? -- Metaanalysen mit unterschiedlichen Resultaten

Woitzek, Katja
July 2011
Praxis (16618157);7/6/2011, Vol. 100 Issue 14, p869
Academic Journal
No abstract available.


Related Articles

  • Statins in the Primary and Secondary Prevention of Cardiovascular Disease in Women. Virani, Salim S. // Texas Heart Institute Journal;2013, Vol. 40 Issue 3, p288 

    The article examines the growing use of statins in the primary and secondary prevention of cardiovascular disease (CVD) in women. The author explores the CVD risks associated with several lipid fractions in men and women. The author discusses the results of the meta-analysis commissioned by the...

  • Evidence needed on statins in prevention.  // Independent Nurse;2/7/2011, p9 

    The article reports on a Cochrane Library study which found insufficient evidence to justify giving cholesterol-lowering statins to patients with no history of heart disease.

  • Why have total cholesterol levels declined in most developed countries?  // BMC Public Health;2011, Vol. 11 Issue 1, p641 

    The article focuses on the study conducted to examine the decreasing total cholesterol levels in most developed countries. It mentions that cholesterol reduction represents a major public health priority to prevent cardiovascular disease in the country. Further it suggests that regulatory and...

  • CONGRESS ROUND-UP.  // Pulse;9/2/2009, Vol. 69 Issue 27, p4 

    The article presents medical news briefs in Great Britain. An analysis found that rates of cardiovascular death, stroke or heart attack were 11.8% in patients in clopidogrel and proton pump inhibitors. A study revealed that statins have benefits for primary prevention in patients over 70 who do...

  • In patients with no history of cardiovascular disease (CVD), what are the benefits and harms of statins? Elley, C. Raina // Annals of Internal Medicine;7/16/2013, Vol. 159 Issue 2, pJC2 

    In this article, the author focuses on a study conducted by researcher F. Taylor and colleagues related to the advantages and disadvantages of using statins in patients with no history of cardiovascular disease (CVD). According to the study, statins reduce risk of CVD and mortality in patients...

  • Statins for primary prevention of cardiovascular disease. Deckers, Jaap W.; Blumenthal, Roger S. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/26/2011, Vol. 342 Issue 7795, p451 

    The article comments on a Cochrane systematic review of the use of statins to prevent cardiovascular disease. The Cochrane review concludes that the benefits of statins will outweigh harm if the risk for cardiovascular disease is more than two percent a year. The authors suggest that the use of...

  • Review: In older patients without CVD, statins reduce MI and stroke but not all-cause mortality. Schaefer, Saul // ACP Journal Club;5/15/2014, Vol. 160 Issue 10, p1 

    In this article, the author discusses benefits of cardiovascular agent statins in older patients without cardiovascular diseases (CVD), and mentions effectiveness of statins whether it reduces CVD. The author also mentions a study with the help of randomized controlled trial (RCT) that statins...

  • Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis. de Vries, Folgerdiena M.; Kolthof, Johan; Postma, Maarten J.; Denig, Petra; Hak, Eelko // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Aims: To estimate the efficacy of standard and intensive statin treatment in the secondary prevention of major cardiovascular and cerebrovascular events in diabetes patients. Methods: A systematic search was conducted in Medline over the years 1990 to September 2013. Randomized, double-blind,...

  • Sex differences in the effectiveness of statins after myocardial infarction. Karp, Igor; Chen, Shun-Fu; Pilote, Louise // CMAJ: Canadian Medical Association Journal;1/30/2007, Vol. 176 Issue 3, p333 

    Background: We sought to investigate the sex differences in the effectiveness of statins in patients with acute myocardial infarction (AMI). Methods: Linking hospital discharge and drug claims databases from Quebec, Canada (1998–2004), we identified statin users (n = 14 710) and non-users...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics